These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15807873

  • 21. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
    Hoeck HC, Jakobsen PE, Vestergaard P, Falhof J, Laurberg P.
    Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
    [Abstract] [Full Text] [Related]

  • 22. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P.
    Ann Neurol; 2006 Nov; 60(5):611-615. PubMed ID: 16958123
    [Abstract] [Full Text] [Related]

  • 23. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ, Hermann KL, Schmahmann JD.
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [Abstract] [Full Text] [Related]

  • 24. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [Abstract] [Full Text] [Related]

  • 25. Red flags for multiple system atrophy.
    Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK, European MSA Study Group.
    Mov Disord; 2008 Jun 15; 23(8):1093-9. PubMed ID: 18442131
    [Abstract] [Full Text] [Related]

  • 26. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC, Thornton JS, Lees AJ, Jäger HR.
    Mov Disord; 2007 Jan 15; 22(1):68-74. PubMed ID: 17089396
    [Abstract] [Full Text] [Related]

  • 27. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
    Yuen KC, Bennett RM, Hryciw CA, Cook MB, Rhoads SA, Cook DM.
    Growth Horm IGF Res; 2007 Feb 15; 17(1):82-8. PubMed ID: 17289417
    [Abstract] [Full Text] [Related]

  • 28. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A, Suzuki K, Miyamoto M, Miyamoto T, Hirata K.
    Parkinsonism Relat Disord; 2014 Feb 15; 20(2):212-6. PubMed ID: 24280021
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone secretion is impaired in amyotrophic lateral sclerosis.
    Morselli LL, Bongioanni P, Genovesi M, Licitra R, Rossi B, Murri L, Rossi G, Martino E, Gasperi M.
    Clin Endocrinol (Oxf); 2006 Sep 15; 65(3):385-8. PubMed ID: 16918961
    [Abstract] [Full Text] [Related]

  • 30. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature.
    Hilczer M, Smyczynska J, Lewinski A.
    Endocr Regul; 2006 Sep 15; 40(3):69-75. PubMed ID: 17100548
    [Abstract] [Full Text] [Related]

  • 31. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
    Kikuchi A, Baba T, Hasegawa T, Sugeno N, Konno M, Takeda A.
    Parkinsonism Relat Disord; 2011 Nov 15; 17(9):698-700. PubMed ID: 21840242
    [Abstract] [Full Text] [Related]

  • 32. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G.
    Eur J Endocrinol; 2005 Aug 15; 153(2):257-64. PubMed ID: 16061832
    [Abstract] [Full Text] [Related]

  • 33. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H, Keller E.
    Clin Endocrinol (Oxf); 2003 Apr 15; 58(4):456-63. PubMed ID: 12641629
    [Abstract] [Full Text] [Related]

  • 34. The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly.
    Gilbert JA, Miell JP, Chambers SM, McGregor AM, Aylwin SJ.
    Clin Endocrinol (Oxf); 2005 Jun 15; 62(6):742-7. PubMed ID: 15943838
    [Abstract] [Full Text] [Related]

  • 35. Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests.
    Giacomozzi C, Spadoni GL, Pedicelli S, Scirè G, Cristofori L, Peschiaroli E, Deodati A, Cambiaso P, Cappa M, Cianfarani S.
    J Endocrinol Invest; 2012 Sep 15; 35(8):742-7. PubMed ID: 21978975
    [Abstract] [Full Text] [Related]

  • 36. Serum prolactin levels in Parkinson's disease and multiple system atrophy.
    Winkler AS, Landau S, Chaudhuri KR.
    Clin Auton Res; 2002 Oct 15; 12(5):393-8. PubMed ID: 12420085
    [Abstract] [Full Text] [Related]

  • 37. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin.
    Cecconi E, Bogazzi F, Morselli LL, Gasperi M, Procopio M, Gramaglia E, Broglio F, Giovannetti C, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2008 Aug 15; 69(2):197-201. PubMed ID: 18221398
    [Abstract] [Full Text] [Related]

  • 38. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 15; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 39. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
    Koutkia P, Eaton K, You SM, Breu J, Grinspoon S.
    AIDS; 2006 Apr 04; 20(6):855-62. PubMed ID: 16549969
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis of adult GH deficiency.
    Ghigo E, Aimaretti G, Corneli G.
    Growth Horm IGF Res; 2008 Feb 04; 18(1):1-16. PubMed ID: 17766155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.